Suppr超能文献

蛋白酶激活受体:图文综述

Protease-activated receptors: An illustrated review.

作者信息

Han Xu, Nieman Marvin T, Kerlin Bryce A

机构信息

Department of Pharmacology Case Western Reserve University Cleveland OH USA.

Center for Clinical and Translational Research Abigail Wexner Research Institute at Nationwide Children's Hospital Columbus OH USA.

出版信息

Res Pract Thromb Haemost. 2020 Dec 6;5(1):17-26. doi: 10.1002/rth2.12454. eCollection 2021 Jan.

Abstract

Proteases are important regulators of cell behavior, survival, and apoptosis. They communicate to cells directly through a special class of G-protein-coupled receptors known as protease-activated receptors (PARs). N-terminal PAR proteolysis unmasks a neo-N-terminus, which serves as a tethered ligand to activate PARs. Using this unique irreversible activation mechanism, PARs relay information across cell membranes. The year 2020 is the 30th year since discovery of the first member of this family, PAR1. In this illustrated review, we highlight achievements in the PAR field over the past 3 decades. Additionally, the known expression profiles of PARs in human tissues and across species are portrayed. We also illustrate the tethered ligand activation mechanism, which is unique to PARs, and PAR regulatory mechanisms. PAR1 was originally named "thrombin receptor" because thrombin was the first protease identified to activate PAR1. However, over the past 30 years, a growing number of proteases have been found to cleave PARs and trigger differential downstream signaling depending on cleavage site, cell type, and species. We exemplify the diversity of PAR1-mediated signaling outcomes in platelets and endothelial cells as pertinent examples to the hemostasis, thrombosis, and vascular biology fields. Further, the termination and regulation of PAR signaling via endocytosis and currently available pharmacologic approaches are depicted. We conclude with portrayal of clinically translational aspects of PAR biology including pharmacologic manipulation and single-nucleotide polymorphisms.

摘要

蛋白酶是细胞行为、存活和凋亡的重要调节因子。它们通过一类特殊的G蛋白偶联受体(称为蛋白酶激活受体,PARs)直接与细胞进行通讯。PARs的N端蛋白水解会暴露出一个新的N端,该N端作为一种拴系配体来激活PARs。利用这种独特的不可逆激活机制,PARs在细胞膜间传递信息。2020年是该家族首个成员PAR1被发现的第30年。在这篇图文并茂的综述中,我们重点介绍了PAR领域在过去30年中的成就。此外,还描绘了PARs在人体组织和不同物种中的已知表达谱。我们还阐述了PARs特有的拴系配体激活机制以及PAR调节机制。PAR1最初被命名为“凝血酶受体”,因为凝血酶是首个被鉴定出可激活PAR1的蛋白酶。然而,在过去30年中,人们发现越来越多的蛋白酶能够切割PARs,并根据切割位点、细胞类型和物种引发不同的下游信号传导。我们以血小板和内皮细胞中PAR1介导的信号转导结果的多样性为例,说明其在止血、血栓形成和血管生物学领域的相关情况。此外,还描述了通过内吞作用对PAR信号的终止和调节以及目前可用的药理学方法。我们最后描述了PAR生物学在临床转化方面的情况,包括药理学操作和单核苷酸多态性。

相似文献

1
Protease-activated receptors: An illustrated review.蛋白酶激活受体:图文综述
Res Pract Thromb Haemost. 2020 Dec 6;5(1):17-26. doi: 10.1002/rth2.12454. eCollection 2021 Jan.
4
Biased signaling of protease-activated receptors.蛋白酶激活受体的偏向性信号传导
Front Endocrinol (Lausanne). 2014 May 13;5:67. doi: 10.3389/fendo.2014.00067. eCollection 2014.
5
Allosteric modulation of protease-activated receptor signaling.变构调节蛋白酶激活受体信号转导。
Mini Rev Med Chem. 2012 Aug;12(9):804-11. doi: 10.2174/138955712800959116.
6
Cofactoring and dimerization of proteinase-activated receptors.蛋白酶激活受体的共因子化和二聚化。
Pharmacol Rev. 2013 Sep 24;65(4):1198-213. doi: 10.1124/pr.111.004747. Print 2013.
8
How the protease thrombin talks to cells.蛋白酶凝血酶如何与细胞进行交流。
Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11023-7. doi: 10.1073/pnas.96.20.11023.

引用本文的文献

1
From theory to platelets: unraveling the history and complexities of biased signaling.从理论到血小板:揭示偏向性信号传导的历史与复杂性
Blood Vessel Thromb Hemost. 2025 May 5;2(3):100073. doi: 10.1016/j.bvth.2025.100073. eCollection 2025 Aug.
9
Endothelial protease-activated receptor 4: impotent or important?内皮蛋白酶激活受体4:无作用还是重要?
Front Cardiovasc Med. 2025 Jan 28;12:1541879. doi: 10.3389/fcvm.2025.1541879. eCollection 2025.

本文引用的文献

9
Challenges and Opportunities in Protease-Activated Receptor Drug Development.蛋白酶激活受体药物研发的挑战与机遇。
Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:349-373. doi: 10.1146/annurev-pharmtox-011613-140016. Epub 2016 Sep 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验